Determinants of pain severity changes in ambulatory patients with cancer: An analysis from eastern cooperative oncology group trial E2Z02

Journal of Clinical Oncology

Volumn 32, Issue 4, 2014, Pages 312-319

  Zhao, Fengmin ^a   Chang, Victor T ^b   Cleeland, Charles ^c   Cleary, James F ^d   Mitchell, Edith P ^e   Wagner, Lynne I ^f   Fisch, Michael J ^c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; OPIATE;

ADULT; AGE DISTRIBUTION; ANALGESIA; ARTICLE; BREAST CANCER; CANCER PAIN; CANCER PATIENT; COLORECTAL CANCER; DEMOGRAPHY; FEMALE; FOLLOW UP; HEALTH STATUS; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSTATE CANCER; RATING SCALE; SOLID TUMOR; TUMOR INVASION; UNEMPLOYMENT; AGED; AMBULATORY CARE; BREAST TUMOR; CLINICAL TRIAL; COLORECTAL TUMOR; LUNG TUMOR; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM; PAIN; PAIN ASSESSMENT; PROSTATE TUMOR; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STANDARD; STATISTICAL MODEL; TIME;

ADULT; AGED; AMBULATORY CARE; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PAIN; PAIN MANAGEMENT; PAIN MEASUREMENT; PROSTATIC NEOPLASMS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84897018922     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.50.6071     Document Type: Article

References (37)

1. Cleeland CS, Gonin R, Hatfield AK, et al: Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 330:592-596, 1994 (Pubitemid 24065792)
2. Fainsinger RL, Nekolaichuk C, Lawlor P, et al: An international multicentre validation study of a pain classification system for cancer patients. Eur J Cancer 46:2896-2904, 2010
3. Wilson KG, Chochinov HM, Allard P, et al: Prevalence and correlates of pain in the Canadian National Palliative Care Survey. Pain Res Manag 14:365-370, 2009
4. Breivik H, Cherny N, Collett B, et al: Cancer-related pain: A pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol 20:1420-1433, 2009
5. van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, et al: Prevalence of pain in patients with cancer: A systematic review of the past 40 years. Ann Oncol 18:1437-1449, 2007 (Pubitemid 47365475)
6. Apolone G, Corli O, Caraceni A, et al: Pattern and quality of care of cancer pain management: Results from the Cancer Pain Outcome Research Study Group. Br J Cancer 100:1566-1574, 2009
7. Deandrea S, Montanari M, Moja L, et al: Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol 19:1985-1991, 2008
8. Fisch MJ, Lee JW, Weiss M, et al: Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol 30:1980-1988, 2012
9. Zhu J, Davis RB, Stuver SO, et al: A longitudinal study of pain variability and its correlates in ambulatory patients with advanced stage cancer. Cancer 118:6278-6286, 2012
10. Wang HL, Kroenke K, Wu J, et al: Cancer-related pain and disability: A longitudinal study. J Pain Symptom Manage 42:813-821, 2011
11. Gaskin DJ, Richard P: The economic costs of pain in the United States. J Pain 13:715-724, 2012
12. Wagner-Johnston ND, Carson KA, Grossman SA: High outpatient pain intensity scores predict impending hospital admissions in patients with cancer. J Pain Symptom Manage 39:180-185, 2010
13. Fortner BV, Okon TA, Portenoy RK: A survey of pain-related hospitalizations, emergency department visits, and physician office visits reported by cancer patients with and without history of breakthrough pain. J Pain 3:38-44, 2002 (Pubitemid 34163489)
14. Dworkin RH, Turk DC, Peirce-Sandner S, et al: Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations. Pain 153:1148-1158, 2012
15. Patrick DL, Ferketich SL, Frame PS, et al: National Institutes of Health State-of-the-Science Conference Statement: Symptom Management in Cancer - Pain, Depression, and Fatigue, July 15-17, 2002. J Natl Cancer Inst 95:1110-1117, 2003
16. Farrar JT, Young JP, LaMoreaux L, et al: Clinical importance of change in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94:149-158, 2001 (Pubitemid 33016608)
17. Anderson KO: Role of cutpoints: Why grade pain intensity? Pain 113:5-6, 2005
18. Farrar JT: Cut-points for the measurement of pain: The choice depends on what you want to study. Pain 149:163-164, 2010
19. Serlin RC, Mendoza TR, Nakamura Y, et al: When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 61:277-284, 1995
20. Fainsinger RL, Nekolaichuk CL, Lawlor PG, et al: A multicenter study of the revised Edmonton Staging System for classifying cancer pain in advanced cancer patients. J Pain Symptom Manage 29:224-237, 2005 (Pubitemid 40386739)
21. Agresti A: Categorical Data Analysis. New York, NY, Wiley, 1990
22. Armitage P: Tests for linear trends in proportions and frequencies Biometrics 11:375-386, 1955
23. Williams RL: A note on robust variance estimation for cluster-correlated data. Biometrics 56:645-646, 2000
24. Yennurajalingam S, Kang JH, Hui D, et al: Clinical response to an outpatient palliative care consultation in patients with advanced cancer and cancer pain. J Pain Symptom Manage 44:340-350, 2012
25. Wang HL, Kroenke K, Wu J, et al: Predictors of cancer-related pain improvement over time. Psychosom Med 74:642-647, 2012
26. Fukshansky M, Are M, Burton AW: The role of opioids in cancer pain management. Pain Pract 5:43-53, 2005
27. Ripamonti CI, Bandieri E, Roila F: Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol 22:vi69-vi77, 2011 (suppl 6)
28. World Health Organization: Cancer Pain Relief (ed 2). Geneva, Switzerland, WHO office of Publication, 1996
29. Ward SE, Goldberg N, Miller-McCauley V, et al: Patient-related barriers to management of cancer pain. Pain 52:319-324, 1993 (Pubitemid 23080550)
30. Caraceni A, Hanks G, Kaasa S, et al: Use of opioid analgesics in the treatment of cancer pain: Evidence-based recommendations from the EAPC. Lancet Oncol 13:e58-e68, 2012
31. Rustøen T, Valeberg BT, Kolstad E, et al: The PRO-SELF pain control program improves patients' knowledge of cancer pain management. J Pain Symptom Manage 44:321-330, 2012
32. Miaskowski C, Dodd M, West C, et al: Randomized clinical trial of the effectiveness of a self-care intervention to improve cancer pain management. J Clin Oncol 22:1713-1720, 2004 (Pubitemid 41079811)
33. Bland JM, Altman DG: Statistic Notes: Regression towards the mean. BMJ 308:1499, 1994 (Pubitemid 24170175)
34. Barnett A, van den Plos JC, Dobson AJ: Regression to the mean: What it is and how to deal with it. Int J Epidemiol 34:215-220, 2005 (Pubitemid 40347398)
35. Fainsinger RL, Fairchild A, Nekolaichuk C, et al: Is pain intensity a predictor of the complexity of cancer pain management? J Clin Oncol 27:585-590, 2009
36. Torrance N, Ferguson JA, Afolabi E, et al: Neuropathic pain in the community: More undertreated than refractory? Pain 154:690-699, 2013
37. Fainsinger RL, Nekolaichuk CL: Cancer pain assessment: Can we predict the need for specialist input? Eur J Cancer 44:1072-1077, 2008